$2.33T
Total marketcap
$90.99B
Total volume
BTC 49.90%     ETH 15.48%
Dominance

Aion Therapeutic ANTCF Stock

0.02 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
6.17M USD
LOW - HIGH [24H]
0.02 - 0.02 USD
VOLUME [24H]
100K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Aion Therapeutic Price Chart

Aion Therapeutic ANTCF Financial and Trading Overview

Aion Therapeutic stock price 0.02 USD
Previous Close 0.0036 USD
Open 0.0036 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 0.0036 - 0.0036 USD
52 Week Range 0.0032 - 0.03 USD
Volume 5.56K USD
Avg. Volume 1.25K USD
Market Cap 553.09K USD
Beta (5Y Monthly) 0.768723
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

ANTCF Valuation Measures

Enterprise Value 1.47M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.243

Trading Information

Aion Therapeutic Stock Price History

Beta (5Y Monthly) 0.768723
52-Week Change -62.77%
S&P500 52-Week Change 20.43%
52 Week High 0.03 USD
52 Week Low 0.0032 USD
50-Day Moving Average 0.0057324 USD
200-Day Moving Average 0.0095305 USD

ANTCF Share Statistics

Avg. Volume (3 month) 1.25K USD
Avg. Daily Volume (10-Days) 555 USD
Shares Outstanding 147.3M
Float N/A
Short Ratio N/A
% Held by Insiders 17.68%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends April 30, 2022
Most Recent Quarter (mrq) January 31, 2023
Next Fiscal Year End April 30, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -77.31%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -1181812 USD
Net Income Avi to Common (ttm) -1152041 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) 938.21K USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.072
Book Value Per Share (mrq) -0.013

Cash Flow Statement

Operating Cash Flow (ttm) -181351 USD
Levered Free Cash Flow (ttm) -525411 USD

Profile of Aion Therapeutic

Country United States
State ON
City Toronto
Address 45 Sheppard Avenue East
ZIP M2N 5W9
Phone N/A
Website N/A
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees N/A

Aion Therapeutic Inc. offer medical cannabis products in Canada. The company was formerly known as Osoyoos Cannabis Inc. and changed its name to Aion Therapeutic Inc. in August 2020. Aion Therapeutic Inc. was incorporated in 2011 and is headquartered in Toronto, Canada.

Q&A For Aion Therapeutic Stock

What is a current ANTCF stock price?

Aion Therapeutic ANTCF stock price today per share is 0.02 USD.

How to purchase Aion Therapeutic stock?

You can buy ANTCF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Aion Therapeutic?

The stock symbol or ticker of Aion Therapeutic is ANTCF.

Which industry does the Aion Therapeutic company belong to?

The Aion Therapeutic industry is Drug Manufacturers-Specialty & Generic.

How many shares does Aion Therapeutic have in circulation?

The max supply of Aion Therapeutic shares is 411.55M.

What is Aion Therapeutic Price to Earnings Ratio (PE Ratio)?

Aion Therapeutic PE Ratio is now.

What was Aion Therapeutic earnings per share over the trailing 12 months (TTM)?

Aion Therapeutic EPS is 0 USD over the trailing 12 months.

Which sector does the Aion Therapeutic company belong to?

The Aion Therapeutic sector is Healthcare.